Clin2
NCT07464873Possibly a fitNot yet recruiting

Testing a visual scale for estimating methamphetamine use

Methamphetamine Disorders

Part of Mental health clinical trials.

This study tests a new picture-based scale to help people estimate how much methamphetamine they use daily. Researchers will check if this scale is reliable and acceptable by comparing it with hair samples.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
20 years to 40 years
Study type
Observational

Who can take part

  • You must be between 20 and 40 years old.
  • You need to be comfortable speaking English.
  • You must have used methamphetamine at least once in the last 7 days.
  • You need at least 1 cm (about half an inch) of untreated hair on the back of your head.
  • Your hair must be naturally brown or black.
  • You must be willing to provide a hair sample.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06721494Recruiting· Phase 2
A single-dose study of CS-1103 for methamphetamine use

This trial tests a single dose of an investigational drug, CS-1103, to see if it is safe and effective for people who use methamphetamine. It may help understand how the drug affects methamphetamine in the body.

Glendale, California
NCT07584369Not yet recruiting· Phase 4
Effects of methamphetamine on hidden HIV

This study looks at how a single dose of methamphetamine affects the hidden HIV that stays in the body even when the virus is undetectable. It may help researchers understand how to better treat or cure HIV in the future.

San Francisco, California
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT07459257Recruiting
Predicting psychiatric symptoms in methamphetamine psychosis

This study looks for patterns in psychiatric symptoms among people who have psychotic symptoms caused by methamphetamine use. You may qualify if you are 18-65, haven't taken psychiatric medication for at least a month, and do not have certain other health conditions.

Elâzığ, Elâzığ
NCT07802223Not yet recruiting
Brain stimulation for methamphetamine addiction

This trial tests a non-invasive brain stimulation technique to help people with methamphetamine addiction reduce their drug use. It aims to improve brain function related to addiction and support recovery.

Shanghai, Shanghai Municipality
NCT06899594Recruiting· Early Phase 1
Psilocybin for quitting methamphetamine

This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.

Shreveport, Louisiana

Hear when a new Methamphetamine Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.